Abstract:Background: Protein theranostics integrate both diagnostic and treatment functions on a single disease-targeting protein. However, the preparation of these multimodal agents remains a major challenge. Ideally, conventional recombinant proteins should be used as starting materials for modification with the desired detection and therapeutic functionalities, but simple chemical strategies that allow the introduction of two different modifications into a protein in a site-specific manner are not currently available. We recently discovered two highly efficient peptide ligases, namely butelase-1 and VyPAL2. Although both ligate at asparaginyl peptide bonds, these two enzymes are bio-orthogonal with distinguishable substrate specificities, which can be exploited to introduce distinct modifications onto a protein.Methods: We quantified substrate specificity differences between butelase-1 and VyPAL2, which provide orthogonality for a tandem ligation method for protein dual modifications. Recombinant proteins or synthetic peptides engineered with the preferred recognition motifs of butelase-1 and VyPAL2 at their respective C- and N-terminal ends could be modified consecutively by the action of the two ligases.Results: Using this method, we modified an EGFR-targeting affibody with a fluorescein tag and a mitochondrion-lytic peptide at its respective N- and C-terminal ends. The dual-labeled protein was found to be a selective bioimaging and cytotoxic agent for EGFR-positive A431 cancer cells. In addition, the method was used to prepare a cyclic form of the affibody conjugated with doxorubicin. Both modified affibodies showed increased cytotoxicity to A431 cells by 10- and 100-fold compared to unconjugated doxorubicin and the free peptide, respectively.Conclusion: Bio-orthogonal tandem ligation using two asparaginyl peptide ligases with differential substrate specificities is a straightforward approach for the preparation of multifunctional protein biologics as potential theranostics.

Expressed protein ligation: A general method for protein engineering

Expressed Protein Ligation Using Subtiligase

Analyzing protein posttranslational modifications using enzyme-catalyzed expressed protein ligation

Expressed protein ligation: a resourceful tool to study protein structure and function

Ligation of expressed protein α-hydrazides via genetic incorporation of an α-hydroxy acid.

Protein ligation: an enabling technology for the biophysical analysis of proteins

The First Semi-Synthetic Serine Protease Made by Native Chemical Ligation

Nature-inspired protein ligation and its applications

Automated Flow Peptide Synthesis Enables Engineering of Proteins with Stabilized Transient Binding Pockets

Rapid and efficient protein synthesis through expansion of the native chemical ligation concept

An Enabling Peptide Ligation Induced by Thiol‐Salicylaldehyde Ester for Chemical Protein Synthesis

Traceless enzymatic protein synthesis without ligation sites constraint

The New Salicylaldehyde S,S-Propanedithioacetal Ester Enables N-to-C Sequential Native Chemical Ligation and Ser/Thr Ligation for Chemical Protein Synthesis

Selective Activation of Peptide‐Thioester Precursors for Templated Native Chemical Ligations

Thioester-Assisted Sortase-A-Mediated Ligation.

Protein Editing using a Concerted Transposition Reaction

A Peptide-Based Ligand-Directed Chemistry Enables Protein Functionalization

Engineering protein theranostics using bio-orthogonal asparaginyl peptide ligases

Applications of Transpeptidase Sortase A for Protein Modifications

Encouraging Solution to the Problem of Synthesizing Protein Α-Thioester

Prior disulfide bond-mediated Ser/Thr ligation